Zevra Therapeutics Inc. (ZVRA)
undefined
undefined%
At close: undefined
8.38
-1.06%
After-hours Dec 13, 2024, 07:54 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue 27.46M 10.46M 28.65M 13.29M 12.84M - - - - - - -
Cost of Revenue 2.94M 343.00K 2.06M 1.30M 2.94M 324.00K 336.00K 175.00K 84.00K - - -
Gross Profit 24.52M 10.12M 26.59M 11.98M 9.89M -324.00K -336.00K -175.00K -84.00K - - -
Operating Income -49.60M -24.84M 7.73M -4.78M -20.34M -55.90M -33.37M -37.48M -22.81M -16.44M -4.72M -5.34M
Interest Income 4.54M 760.00K 248.00K 89.00K 309.00K 420.00K 365.00K 353.00K 32.00K 4.28K 52.00K 34.73K
Pretax Income -46.05M -42.33M -8.52M -12.79M -24.54M -56.59M -43.43M -16.53M -54.64M -24.48M -5.25M -107.64K
Net Income -46.05M -41.54M -8.55M -12.76M -24.52M -56.47M -43.39M -16.52M -54.66M -24.45M -5.23M -70.42K
Selling & General & Admin 35.09M 15.34M 8.70M 7.92M 10.82M 12.51M 12.77M 14.00M 8.88M 4.53M 1.35M 2.34M
Research & Development 39.81M 19.61M 10.16M 8.84M 19.41M 41.76M 20.59M 20.47M 13.93M 11.92M 3.37M 2.99M
Other Expenses -775.00K - - - - - - - -31.82M - - -
Operating Expenses 74.12M 34.96M 18.86M 16.76M 30.23M 54.27M 33.37M 34.47M 22.81M 16.44M 4.72M 142.38K
Interest Expense 1.50M 335.00K 376.00K 7.09M 6.51M 7.09M 7.34M 7.13M 2.67M 2.72M 157.00K -
Selling & Marketing Expenses - - - - - - - - - 93.00 - -
Cost & Expenses 77.06M 35.30M 20.92M 18.07M 33.18M 54.27M 33.37M 34.47M 22.81M 16.44M 4.72M 142.38K
Income Tax - -786.00K 34.00K -34.00K -22.00K -126.00K -43.00K -15.00K 26.00K -22.25K -20.00K 37.23K
Shares Outstanding (Basic) 35.45M 34.49M 29.77M 3.98M 1.85M 1.12M 915.81K 912.32K 460.54K 769.24K 488.96K 148.70K
Shares Outstanding (Diluted) 35.45M 34.49M 29.77M 3.98M 1.85M 1.12M 915.81K 912.32K 460.54K 769.24K 488.96K 148.70K
EPS (Basic) -1.3 -1.2 -0.29 -3.21 -13.23 -50.39 -47.37 -18.1 -118.69 -31.79 -10.69 -0.47
EPS (Diluted) -1.3 -1.2 -0.29 -3.21 -13.23 -50.39 -47.37 -18.1 -118.69 -31.79 -10.69 -0.47
EBITDA -48.60M -25.53M -7.89M -5.43M -17.73M -53.94M -33.03M -34.30M -22.73M -16.37M -4.65M 368.89K
Depreciation & Amortization 1.01M 944.00K 257.00K 273.00K 304.00K 324.00K 336.00K 175.00K 84.00K 74.76K 68.00K 62.56K